BACKGROUND: Oral direct-acting antivirals (DAAs) provide an exceptional opportunity to treat hepatitis C virus (HCV) infection.
GOALS: We compared the treatment outcomes between specialty and primary care physician (PCP) clinics for patients treated with DAAs.
METHODS: We performed a retrospective analysis of patients treated for HCV in our PCP clinics and specialty; liver and gastroenterology clinics and gastroenterology clinics. We used the two-sided
RESULTS: Data from a total of 377 patients was analyzed (PCP clinic:
CONCLUSIONS: Uncomplicated patients can be treated for hepatitis C by their PCPs with DAAs with similar treatment outcomes to specialty clinics. There should be explicit guidelines on patient eligibility for treatment by PCPs vs. specialists.
Syed TA, Bashir MH, Farooqui SM, Chen A, Chen S, Nusrat S, Fazili J. Treatment Outcomes of Hepatitis C-Infected Patients in Specialty Clinic vs. Primary Care Physician Clinic: A Comparative Analysis. Gastroenterol Res Pract. 2019 Jun 4;2019:8434602. doi: 10.1155/2019/8434602. PMID: 31281352; PMCID: PMC6589298.